585 related articles for article (PubMed ID: 9508775)
21. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP
Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615
[TBL] [Abstract][Full Text] [Related]
22. Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5'-monophosphate and growth factors.
Vandeput F; Perpete S; Coulonval K; Lamy F; Dumont JE
Endocrinology; 2003 Apr; 144(4):1341-9. PubMed ID: 12639917
[TBL] [Abstract][Full Text] [Related]
23. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of protooncogenes c-jun and jun D expressions by protein tyrosine kinase, protein kinase C, and cyclic-AMP mitogenic pathways in dog primary thyrocytes: TSH and cyclic-AMP induce proliferation but downregulate C-jun expression.
Reuse S; Pirson I; Dumont JE
Exp Cell Res; 1991 Oct; 196(2):210-5. PubMed ID: 1654270
[TBL] [Abstract][Full Text] [Related]
25. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
Tanguay DA; Chiles TC
J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E x cyclin-dependent kinase 2 complexes.
Medina DL; Toro MJ; Santisteban P
J Biol Chem; 2000 May; 275(20):15549-56. PubMed ID: 10809788
[TBL] [Abstract][Full Text] [Related]
28. Coupling of epidermal growth factor (EGF) with the antiproliferative activity of cAMP induces neuronal differentiation.
Mark MD; Storm DR
J Biol Chem; 1997 Jul; 272(27):17238-44. PubMed ID: 9202048
[TBL] [Abstract][Full Text] [Related]
29. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
30. TSH and cAMP do not signal mitogenesis through Ras activation.
Van Keymeulen A; Roger PP; Dumont JE; Dremier S
Biochem Biophys Res Commun; 2000 Jun; 273(1):154-8. PubMed ID: 10873578
[TBL] [Abstract][Full Text] [Related]
31. Protein synthesis during induction of DNA replication in thyroid epithelial cells: evidence for late markers of distinct mitogenic pathways.
Lamy F; Roger P; Lecocq R; Dumont JE
J Cell Physiol; 1989 Mar; 138(3):568-78. PubMed ID: 2647771
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase.
Bacon CL; Gallagher HC; Haughey JC; Regan CM
J Neurochem; 2002 Oct; 83(1):12-9. PubMed ID: 12358724
[TBL] [Abstract][Full Text] [Related]
33. IGF-1 or insulin, and the TSH cyclic AMP cascade separately control dog and human thyroid cell growth and DNA synthesis, and complement each other in inducing mitogenesis.
Deleu S; Pirson I; Coulonval K; Drouin A; Taton M; Clermont F; Roger PP; Nakamura T; Dumont JE; Maenhaut C
Mol Cell Endocrinol; 1999 Mar; 149(1-2):41-51. PubMed ID: 10375016
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
[TBL] [Abstract][Full Text] [Related]
35. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway.
Lamy F; Wilkin F; Baptist M; Posada J; Roger PP; Dumont JE
J Biol Chem; 1993 Apr; 268(12):8398-401. PubMed ID: 8386160
[TBL] [Abstract][Full Text] [Related]
37. A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors.
Roger PP; Baptist M; Dumont JE
J Cell Biol; 1992 Apr; 117(2):383-93. PubMed ID: 1313816
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
40. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint.
Lukas J; Bartkova J; Bartek J
Mol Cell Biol; 1996 Dec; 16(12):6917-25. PubMed ID: 8943347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
